[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Antibody Drug Conjugates Market Report 2017

October 2017 | 113 pages | ID: A129412800DEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Antibody Drug Conjugates market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Antibody Drug Conjugates for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Antibody Drug Conjugates market competition by top manufacturers/players, with Antibody Drug Conjugates sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • F.Hoffman-La Roche
  • Novartis
  • Takeda Pharmaceutial
  • Pfizer
  • Seattle Genetics
  • Genentech
  • Immunogen
  • Immunomedics
  • Progenics Pharmaceutical
  • Bayer Healthcare Pharmaceutical
  • Agensys
  • Concortis Biotherapeutics
  • Sanofi
  • Celldex Therapeutics
  • Synthon Holding
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
  • Adcetris
  • Kadcyla
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Antibody Drug Conjugates for each application, includin
  • Breast Cancer
  • Lymphoma
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Antibody Drug Conjugates Market Report 2017

1 ANTIBODY DRUG CONJUGATES OVERVIEW

1.1 Product Overview and Scope of Antibody Drug Conjugates
1.2 Classification of Antibody Drug Conjugates by Product Category
  1.2.1 Asia-Pacific Antibody Drug Conjugates Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Antibody Drug Conjugates Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Adcetris
  1.2.4 Kadcyla
1.3 Asia-Pacific Antibody Drug Conjugates Market by Application/End Users
  1.3.1 Asia-Pacific Antibody Drug Conjugates Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Breast Cancer
  1.3.3 Lymphoma
1.4 Asia-Pacific Antibody Drug Conjugates Market by Region
  1.4.1 Asia-Pacific Antibody Drug Conjugates Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Antibody Drug Conjugates (2012-2022)
  1.5.1 Asia-Pacific Antibody Drug Conjugates Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Antibody Drug Conjugates Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC ANTIBODY DRUG CONJUGATES COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Antibody Drug Conjugates Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Antibody Drug Conjugates Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Antibody Drug Conjugates Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Antibody Drug Conjugates (Volume and Value) by Type
  2.2.1 Asia-Pacific Antibody Drug Conjugates Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Antibody Drug Conjugates Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Antibody Drug Conjugates (Volume) by Application
2.4 Asia-Pacific Antibody Drug Conjugates (Volume and Value) by Region
  2.4.1 Asia-Pacific Antibody Drug Conjugates Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Antibody Drug Conjugates Revenue and Market Share by Region (2012-2017)

3 CHINA ANTIBODY DRUG CONJUGATES (VOLUME, VALUE AND SALES PRICE)

3.1 China Antibody Drug Conjugates Sales and Value (2012-2017)
  3.1.1 China Antibody Drug Conjugates Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Antibody Drug Conjugates Revenue and Growth Rate (2012-2017)
  3.1.3 China Antibody Drug Conjugates Sales Price Trend (2012-2017)
3.2 China Antibody Drug Conjugates Sales Volume and Market Share by Type
3.3 China Antibody Drug Conjugates Sales Volume and Market Share by Application

4 JAPAN ANTIBODY DRUG CONJUGATES (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Antibody Drug Conjugates Sales and Value (2012-2017)
  4.1.1 Japan Antibody Drug Conjugates Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Antibody Drug Conjugates Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Antibody Drug Conjugates Sales Price Trend (2012-2017)
4.2 Japan Antibody Drug Conjugates Sales Volume and Market Share by Type
4.3 Japan Antibody Drug Conjugates Sales Volume and Market Share by Application

5 SOUTH KOREA ANTIBODY DRUG CONJUGATES (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Antibody Drug Conjugates Sales and Value (2012-2017)
  5.1.1 South Korea Antibody Drug Conjugates Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Antibody Drug Conjugates Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Antibody Drug Conjugates Sales Price Trend (2012-2017)
5.2 South Korea Antibody Drug Conjugates Sales Volume and Market Share by Type
5.3 South Korea Antibody Drug Conjugates Sales Volume and Market Share by Application

6 TAIWAN ANTIBODY DRUG CONJUGATES (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Antibody Drug Conjugates Sales and Value (2012-2017)
  6.1.1 Taiwan Antibody Drug Conjugates Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Antibody Drug Conjugates Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Antibody Drug Conjugates Sales Price Trend (2012-2017)
6.2 Taiwan Antibody Drug Conjugates Sales Volume and Market Share by Type
6.3 Taiwan Antibody Drug Conjugates Sales Volume and Market Share by Application

7 INDIA ANTIBODY DRUG CONJUGATES (VOLUME, VALUE AND SALES PRICE)

7.1 India Antibody Drug Conjugates Sales and Value (2012-2017)
  7.1.1 India Antibody Drug Conjugates Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Antibody Drug Conjugates Revenue and Growth Rate (2012-2017)
  7.1.3 India Antibody Drug Conjugates Sales Price Trend (2012-2017)
7.2 India Antibody Drug Conjugates Sales Volume and Market Share by Type
7.3 India Antibody Drug Conjugates Sales Volume and Market Share by Application

8 SOUTHEAST ASIA ANTIBODY DRUG CONJUGATES (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Antibody Drug Conjugates Sales and Value (2012-2017)
  8.1.1 Southeast Asia Antibody Drug Conjugates Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Antibody Drug Conjugates Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Antibody Drug Conjugates Sales Price Trend (2012-2017)
8.2 Southeast Asia Antibody Drug Conjugates Sales Volume and Market Share by Type
8.3 Southeast Asia Antibody Drug Conjugates Sales Volume and Market Share by Application

9 AUSTRALIA ANTIBODY DRUG CONJUGATES (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Antibody Drug Conjugates Sales and Value (2012-2017)
  9.1.1 Australia Antibody Drug Conjugates Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Antibody Drug Conjugates Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Antibody Drug Conjugates Sales Price Trend (2012-2017)
9.2 Australia Antibody Drug Conjugates Sales Volume and Market Share by Type
9.3 Australia Antibody Drug Conjugates Sales Volume and Market Share by Application

10 ASIA-PACIFIC ANTIBODY DRUG CONJUGATES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 F.Hoffman-La Roche
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Antibody Drug Conjugates Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 F.Hoffman-La Roche Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Novartis
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Antibody Drug Conjugates Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Novartis Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Takeda Pharmaceutial
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Antibody Drug Conjugates Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Takeda Pharmaceutial Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Pfizer
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Antibody Drug Conjugates Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Pfizer Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Seattle Genetics
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Antibody Drug Conjugates Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Seattle Genetics Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Genentech
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Antibody Drug Conjugates Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Genentech Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Immunogen
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Antibody Drug Conjugates Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Immunogen Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Immunomedics
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Antibody Drug Conjugates Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Immunomedics Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Progenics Pharmaceutical
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Antibody Drug Conjugates Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Progenics Pharmaceutical Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Bayer Healthcare Pharmaceutical
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Antibody Drug Conjugates Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Bayer Healthcare Pharmaceutical Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 Agensys
10.12 Concortis Biotherapeutics
10.13 Sanofi
10.14 Celldex Therapeutics
10.15 Synthon Holding

11 ANTIBODY DRUG CONJUGATES MANUFACTURING COST ANALYSIS

11.1 Antibody Drug Conjugates Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Antibody Drug Conjugates

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Antibody Drug Conjugates Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Antibody Drug Conjugates Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC ANTIBODY DRUG CONJUGATES MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Antibody Drug Conjugates Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Antibody Drug Conjugates Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Antibody Drug Conjugates Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Antibody Drug Conjugates Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Antibody Drug Conjugates Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Antibody Drug Conjugates Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Antibody Drug Conjugates Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Antibody Drug Conjugates Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Antibody Drug Conjugates Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Antibody Drug Conjugates Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Antibody Drug Conjugates Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Antibody Drug Conjugates Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Antibody Drug Conjugates Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Antibody Drug Conjugates Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Antibody Drug Conjugates Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Antibody Drug Conjugates Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Antibody Drug Conjugates Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Antibody Drug Conjugates Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Antibody Drug Conjugates Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Antibody Drug Conjugates
Figure Asia-Pacific Antibody Drug Conjugates Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific Antibody Drug Conjugates Sales Volume Market Share by Type (Product Category) in 2016
Figure Adcetris Product Picture
Figure Kadcyla Product Picture
Figure Asia-Pacific Antibody Drug Conjugates Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Antibody Drug Conjugates by Application in 2016
Figure Breast Cancer Examples
Table Key Downstream Customer in Breast Cancer
Figure Lymphoma Examples
Table Key Downstream Customer in Lymphoma
Figure Asia-Pacific Antibody Drug Conjugates Market Size (Million USD) by Region (2012-2022)
Figure China Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Antibody Drug Conjugates Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Antibody Drug Conjugates Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific Antibody Drug Conjugates Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Antibody Drug Conjugates Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Antibody Drug Conjugates Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Antibody Drug Conjugates Sales Share by Players/Suppliers
Figure Asia-Pacific Antibody Drug Conjugates Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Antibody Drug Conjugates Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Antibody Drug Conjugates Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Antibody Drug Conjugates Revenue Share by Players
Figure 2017 Asia-Pacific Antibody Drug Conjugates Revenue Share by Players
Table Asia-Pacific Antibody Drug Conjugates Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Antibody Drug Conjugates Sales Share by Type (2012-2017)
Figure Sales Market Share of Antibody Drug Conjugates by Type (2012-2017)
Figure Asia-Pacific Antibody Drug Conjugates Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Antibody Drug Conjugates Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Antibody Drug Conjugates Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antibody Drug Conjugates by Type (2012-2017)
Figure Asia-Pacific Antibody Drug Conjugates Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Antibody Drug Conjugates Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific Antibody Drug Conjugates Sales Share by Region (2012-2017)
Figure Sales Market Share of Antibody Drug Conjugates by Region (2012-2017)
Figure Asia-Pacific Antibody Drug Conjugates Sales Market Share by Region in 2016
Table Asia-Pacific Antibody Drug Conjugates Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Antibody Drug Conjugates Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Antibody Drug Conjugates by Region (2012-2017)
Figure Asia-Pacific Antibody Drug Conjugates Revenue Market Share by Region in 2016
Table Asia-Pacific Antibody Drug Conjugates Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific Antibody Drug Conjugates Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Antibody Drug Conjugates Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Antibody Drug Conjugates Sales Market Share by Application (2012-2017)
Figure China Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure China Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Antibody Drug Conjugates Sales Price (USD/Unit) Trend (2012-2017)
Table China Antibody Drug Conjugates Sales Volume (K Units) by Type (2012-2017)
Table China Antibody Drug Conjugates Sales Volume Market Share by Type (2012-2017)
Figure China Antibody Drug Conjugates Sales Volume Market Share by Type in 2016
Table China Antibody Drug Conjugates Sales Volume (K Units) by Applications (2012-2017)
Table China Antibody Drug Conjugates Sales Volume Market Share by Application (2012-2017)
Figure China Antibody Drug Conjugates Sales Volume Market Share by Application in 2016
Figure Japan Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Antibody Drug Conjugates Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Antibody Drug Conjugates Sales Volume (K Units) by Type (2012-2017)
Table Japan Antibody Drug Conjugates Sales Volume Market Share by Type (2012-2017)
Figure Japan Antibody Drug Conjugates Sales Volume Market Share by Type in 2016
Table Japan Antibody Drug Conjugates Sales Volume (K Units) by Applications (2012-2017)
Table Japan Antibody Drug Conjugates Sales Volume Market Share by Application (2012-2017)
Figure Japan Antibody Drug Conjugates Sales Volume Market Share by Application in 2016
Figure South Korea Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Antibody Drug Conjugates Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea Antibody Drug Conjugates Sales Volume (K Units) by Type (2012-2017)
Table South Korea Antibody Drug Conjugates Sales Volume Market Share by Type (2012-2017)
Figure South Korea Antibody Drug Conjugates Sales Volume Market Share by Type in 2016
Table South Korea Antibody Drug Conjugates Sales Volume (K Units) by Applications (2012-2017)
Table South Korea Antibody Drug Conjugates Sales Volume Market Share by Application (2012-2017)
Figure South Korea Antibody Drug Conjugates Sales Volume Market Share by Application in 2016
Figure Taiwan Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Antibody Drug Conjugates Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan Antibody Drug Conjugates Sales Volume (K Units) by Type (2012-2017)
Table Taiwan Antibody Drug Conjugates Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Antibody Drug Conjugates Sales Volume Market Share by Type in 2016
Table Taiwan Antibody Drug Conjugates Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan Antibody Drug Conjugates Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Antibody Drug Conjugates Sales Volume Market Share by Application in 2016
Figure India Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure India Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Antibody Drug Conjugates Sales Price (USD/Unit) Trend (2012-2017)
Table India Antibody Drug Conjugates Sales Volume (K Units) by Type (2012-2017)
Table India Antibody Drug Conjugates Sales Volume Market Share by Type (2012-2017)
Figure India Antibody Drug Conjugates Sales Volume Market Share by Type in 2016
Table India Antibody Drug Conjugates Sales Volume (K Units) by Application (2012-2017)
Table India Antibody Drug Conjugates Sales Volume Market Share by Application (2012-2017)
Figure India Antibody Drug Conjugates Sales Volume Market Share by Application in 2016
Figure Southeast Asia Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Antibody Drug Conjugates Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Antibody Drug Conjugates Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Antibody Drug Conjugates Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Antibody Drug Conjugates Sales Volume Market Share by Type in 2016
Table Southeast Asia Antibody Drug Conjugates Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia Antibody Drug Conjugates Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Antibody Drug Conjugates Sales Volume Market Share by Application in 2016
Figure Australia Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Australia Antibody Drug Conjugates Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Antibody Drug Conjugates Sales Price (USD/Unit) Trend (2012-2017)
Table Australia Antibody Drug Conjugates Sales Volume (K Units) by Type (2012-2017)
Table Australia Antibody Drug Conjugates Sales Volume Market Share by Type (2012-2017)
Figure Australia Antibody Drug Conjugates Sales Volume Market Share by Type in 2016
Table Australia Antibody Drug Conjugates Sales Volume (K Units) by Applications (2012-2017)
Table Australia Antibody Drug Conjugates Sales Volume Market Share by Application (2012-2017)
Figure Australia Antibody Drug Conjugates Sales Volume Market Share by Application in 2016
Table F.Hoffman-La Roche Antibody Drug Conjugates Basic Information List
Table F.Hoffman-La Roche Antibody Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F.Hoffman-La Roche Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure F.Hoffman-La Roche Antibody Drug Conjugates Sales Market Share in Asia-Pacific (2012-2017)
Figure F.Hoffman-La Roche Antibody Drug Conjugates Revenue Market Share in Asia-Pacific (2012-2017)
Table Novartis Antibody Drug Conjugates Basic Information List
Table Novartis Antibody Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis Antibody Drug Conjugates Sales Market Share in Asia-Pacific (2012-2017)
Figure Novartis Antibody Drug Conjugates Revenue Market Share in Asia-Pacific (2012-2017)
Table Takeda Pharmaceutial Antibody Drug Conjugates Basic Information List
Table Takeda Pharmaceutial Antibody Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Takeda Pharmaceutial Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Takeda Pharmaceutial Antibody Drug Conjugates Sales Market Share in Asia-Pacific (2012-2017)
Figure Takeda Pharmaceutial Antibody Drug Conjugates Revenue Market Share in Asia-Pacific (2012-2017)
Table Pfizer Antibody Drug Conjugates Basic Information List
Table Pfizer Antibody Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Antibody Drug Conjugates Sales Market Share in Asia-Pacific (2012-2017)
Figure Pfizer Antibody Drug Conjugates Revenue Market Share in Asia-Pacific (2012-2017)
Table Seattle Genetics Antibody Drug Conjugates Basic Information List
Table Seattle Genetics Antibody Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Seattle Genetics Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Seattle Genetics Antibody Drug Conjugates Sales Market Share in Asia-Pacific (2012-2017)
Figure Seattle Genetics Antibody Drug Conjugates Revenue Market Share in Asia-Pacific (2012-2017)
Table Genentech Antibody Drug Conjugates Basic Information List
Table Genentech Antibody Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Genentech Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Genentech Antibody Drug Conjugates Sales Market Share in Asia-Pacific (2012-2017)
Figure Genentech Antibody Drug Conjugates Revenue Market Share in Asia-Pacific (2012-2017)
Table Immunogen Antibody Drug Conjugates Basic Information List
Table Immunogen Antibody Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Immunogen Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Immunogen Antibody Drug Conjugates Sales Market Share in Asia-Pacific (2012-2017)
Figure Immunogen Antibody Drug Conjugates Revenue Market Share in Asia-Pacific (2012-2017)
Table Immunomedics Antibody Drug Conjugates Basic Information List
Table Immunomedics Antibody Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Immunomedics Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Immunomedics Antibody Drug Conjugates Sales Market Share in Asia-Pacific (2012-2017)
Figure Immunomedics Antibody Drug Conjugates Revenue Market Share in Asia-Pacific (2012-2017)
Table Progenics Pharmaceutical Antibody Drug Conjugates Basic Information List
Table Progenics Pharmaceutical Antibody Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Progenics Pharmaceutical Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Progenics Pharmaceutical Antibody Drug Conjugates Sales Market Share in Asia-Pacific (2012-2017)
Figure Progenics Pharmaceutical Antibody Drug Conjugates Revenue Market Share in Asia-Pacific (2012-2017)
Table Bayer Healthcare Pharmaceutical Antibody Drug Conjugates Basic Information List
Table Bayer Healthcare Pharmaceutical Antibody Drug Conjugates Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Healthcare Pharmaceutical Antibody Drug Conjugates Sales (K Units) and Growth Rate (2012-2017)
Figure Bayer Healthcare Pharmaceutical Antibody Drug Conjugates Sales Market Share in Asia-Pacific (2012-2017)
Figure Bayer Healthcare Pharmaceutical Antibody Drug Conjugates Revenue Market Share in Asia-Pacific (2012-2017)
Table Agensys Antibody Drug Conjugates Basic Information List
Table Concortis Biotherapeutics Antibody Drug Conjugates Basic Information List
Table Sanofi Antibody Drug Conjugates Basic Information List
Table Celldex Therapeutics Antibody Drug Conjugates Basic Information List
Table Synthon Holding Antibody Drug Conjugates Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibody Drug Conjugates
Figure Manufacturing Process Analysis of Antibody Drug Conjugates
Figure Antibody Drug Conjugates Industrial Chain Analysis
Table Raw Materials Sources of Antibody Drug Conjugates Major Manufacturers in 2016
Table Major Buyers of Antibody Drug Conjugates
Table Distributors/Traders List
Figure Asia-Pacific Antibody Drug Conjugates Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Antibody Drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Antibody Drug Conjugates Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific Antibody Drug Conjugates Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific Antibody Drug Conjugates Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Antibody Drug Conjugates Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Antibody Drug Conjugates Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Antibody Drug Conjugates Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Antibody Drug Conjugates Revenue Market Share Forecast by Region in 2022
Figure China Antibody Drug Conjugates Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China Antibody Drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Antibody Drug Conjugates Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Antibody Drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Antibody Drug Conjugates Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea Antibody Drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Antibody Drug Conjugates Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan Antibody Drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Antibody Drug Conjugates Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India Antibody Drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Antibody Drug Conjugates Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Antibody Drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Antibody Drug Conjugates Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia Antibody Drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Antibody Drug Conjugates Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific Antibody Drug Conjugates Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Antibody Drug Conjugates Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Antibody Drug Conjugates Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Antibody Drug Conjugates Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific Antibody Drug Conjugates Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific Antibody Drug Conjugates Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories